Sionna Therapeutics SION
NASDAQ SION
$4.89 -0.21 (-4.22%)
As of: Oct 2, 2026 · 2:18 PM EDT

Sionna Therapeutics (SION) Return on Assets [ROA] (2025 - 2026)

Updated

Sionna Therapeutics' Return on Assets [ROA] was -33.13% in Q2 2026, down 11.92 percentage points from -21.21% a year earlier and down 5.93 percentage points from the prior quarter.

Analysis

Sionna Therapeutics (SION) Return on Assets [ROA] (2025 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Sionna Therapeutics came in at -29.58%.

  • Per Business Quant data, SION's Return on Assets [ROA] in the three quarters before Q2 2026 was -27.20% (Q1 2026), -22.76% (Q4 2025) and -20.62% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Sionna Therapeutics 237.56 Mn 237.56 Mn - -33.13%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -33.13%
Mar 31, 2026 -27.20%
Dec 31, 2025 -22.76%
Sep 30, 2025 -20.62%
Jun 30, 2025 -21.21%
Mar 31, 2025 -24.14%
API Access

Sionna Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SION&period=max&api_key=YOUR_API_KEY